Harinder Singh, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1455 E Ridge Rd, Rochester, NY 14621 Phone: 585-922-4882 Fax: 585-922-4936 |
Dr. Arshad Sami, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 585-922-2908 |
Dr. Dylan Max Ruebeck, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Elmwood Ave, Box Med, Rochester, NY 14642 Phone: 585-275-2222 |
Katherine Nicholson, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Elmwood Ave., Rochester, NY 14642 Phone: 585-275-4912 Fax: 585-276-2144 |
Dr. Imeh Sampson Jr., D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 |
Andras Szeles, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-1900 |
Suzan A Saber, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Avenue, Rochester, NY 14621 Phone: 585-922-5067 Fax: 585-922-2908 |
Fady Makdisy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1555 Long Pond Rd, Rochester, NY 14626 Phone: 585-723-7870 Fax: 585-723-7871 |
Dr. Sree Sindhura Kolli, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 |
Dr. Fatima Masrur, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Box 287, Rochester, NY 14621 Phone: 585-922-5067 Fax: 585-922-2908 |
Fatima Shahid, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Elmwood Ave, Rochester, NY 14642 Phone: 585-275-4912 Fax: 585-276-2144 |
Daniel Chun, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 601 Elmwood Ave, Rochester, NY 14642 Phone: 585-275-4912 |
Patricia Wilke, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 585-922-2908 |
Ryan J Magnuson, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Elmwood Ave, Rochester, NY 14642 Phone: 585-275-4161 Fax: 585-273-1126 |
Dr. David Gerling, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4000 |
Dr. Mark Steven Mcfarland, MD, MSC Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4136 Fax: 585-922-5761 |
Dr. Matthew J. Fleig, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 1736 E Ridge Rd, Rochester, NY 14622 Phone: 585-270-8971 Fax: 585-270-8976 |
Bushra Tbakhi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 601 Elmwood Ave, Rochester, NY 14642 Phone: 585-752-5823 Fax: 585-273-1051 |
Sabita Budhathoki, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester General Hospital, Rochester, NY 14621 Phone: 585-922-4829 |
Manuel Matos, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1555 Long Pond Rd, Dept. Of Medicine-hospitalist, Rochester, NY 14626 Phone: 585-723-7870 Fax: 585-723-7871 |
News Archive
A report from the Department of Health and Human Services' inspector general to be released Friday will call for closer scrutiny of doctors' total billing. Elsewhere, ProPublica looks at how ineffective federal oversight is in looking for fraud in Medicare prescribing.
Researchers have modeled the progression and severity of COVID-19. Their study titled "Estimates of the severity of coronavirus disease 2019: a model-based analysis" was published in the latest issue of The Lancet Infectious Diseases.
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 4 days ago